Filing Details
- Accession Number:
- 0000896262-21-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 20:01:43
- Reporting Period:
- 2021-02-26
- Accepted Time:
- 2021-03-02 20:01:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896262 | Amedisys Inc | AMED | Services-Home Health Care Services (8082) | 113131700 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543701 | G Scott Ginn | 3854 American Way, Suite A Baton Rouge LA 70816 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-26 | 975 | $27.35 | 30,084 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-26 | 975 | $264.15 | 29,109 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-26 | 975 | $0.00 | 975 | $27.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,925 | 2025-05-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,714 | Indirect | Through 401(k) Plan |
Footnotes
- The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
- These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The information in this report is based on a plan statement dated as of December 31, 2020.
- On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 5,625 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019 and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, 2,925 of the 2018 Tranche Options remain unexercised.